M&A

  • A commercial building displays a “Boston Scientific” sign on its exterior. The structure features a smooth white facade with reflective windows and minimal architectural detailing, set against a partly cloudy sky.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Medtech M&A starts off strong in 2026

    Boston Scientific's planned $14.5 billion acquisition of Penumbra is the largest deal of the year so far.

    By • Feb. 26, 2026
  • A sign with company logo in red on a white background at the entrance to Johnson & JOhnson medical device unit
    Image attribution tooltip
    Mario Tama/Getty via Getty Images
    Image attribution tooltip

    Quantum Surgical buys J&J’s NeuWave

    Quantum, developer of the Epione robotic platform for cancer treatment, said the acquisition supports its strategy of reducing cancer mortality through robot-assisted tumor ablation.

    By • Feb. 25, 2026
  • A lab technician runs Guardant Health's Shield blood test for colorectal cancer screening in a lab.
    Image attribution tooltip
    Courtesy of Business Wire
    Image attribution tooltip

    Guardant buys MetaSight for $59M upfront to acquire blood test tech

    MetaSight uses metabolomics, lipidomics and proteomics mass spectrometry technologies to develop tests for specific diseases, including conditions outside of oncology.

    By • Feb. 23, 2026
  • A closeup of an entryway that reads the Federal Trade Commission.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Federal judge strikes down FTC rule expanding premerger reporting requirements

    The regulation required firms to provide more details ahead of mergers, likely chilling dealmaking. The Federal Trade Commission could appeal the ruling.

    By Emily Olsen • Feb. 19, 2026
  • A picture of Masimo's headquarters building.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Danaher to buy Masimo for $9.9B to boost diagnostics portfolio

    Masimo’s board considered other potential partners before determining Danaher was an “ideal fit,” executives at the patient monitoring company said.

    By • Feb. 17, 2026
  • Image attribution tooltip
    Justin Sullivan via Getty Images
    Image attribution tooltip

    Labcorp closes takeover of Empire City assets to fuel New York expansion

    The company struck three deals in New York last year as part of its push to acquire hospital and regional testing labs.

    By • Feb. 11, 2026
  • The CathWorks FFRangio System on a cart.
    Image attribution tooltip
    Permission granted by CathWorks
    Image attribution tooltip

    Medtronic to acquire CathWorks for up to $585M

    The purchase will give Medtronic a larger presence in the cath lab, with a tool to help diagnose and treat coronary artery disease.

    By • Feb. 3, 2026
  • Aerial view of a sprawling Boston Scientific manufacturing plant
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Top medtech trends to watch in 2026

    From M&A to surgical robotics and user fee negotiations, the medical device industry has a busy year ahead. Check out MedTech Dive’s roundup of the top medtech trends to watch in 2026.

    By • Jan. 29, 2026
  • Modern glass and metal office building with a reflective blue-tinted facade, set against a clear blue sky. In the foreground, a large black and white sign reads “Abbott” with the company’s stylized logo and the number “645.” The area has neatly cut grass and a few small trees.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Medtech M&A took off in the second half of 2025: report

    Acquisitions and spinoffs in 2025 surpassed the previous three years, according to a report from Bain & Company.

    By • Jan. 28, 2026
  • Becton Dickinson logo
    Image attribution tooltip
    Permission granted by Becton Dickinson
    Image attribution tooltip

    BD, Waters set completion date for $17.5B biosciences and diagnostics merger

    With Waters stockholders voting to issue shares, the companies are targeting a Feb. 9 close date for the deal.

    By • Jan. 28, 2026
  • A commercial building displays a “Boston Scientific” sign on its exterior. The structure features a smooth white facade with reflective windows and minimal architectural detailing, set against a partly cloudy sky.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    3 takeaways from Boston Scientific’s $14.5B Penumbra deal

    Penumbra is expected to give Boston Scientific more of a presence in the vascular surgery market, with little overlap between the two companies’ products.

    By • Jan. 20, 2026
  • Photo of Michael F. Mahoney, CEO of Boston Scientific.
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Boston Scientific to acquire Penumbra for $14.5B

    With the planned purchase, Boston Scientific will gain several thrombectomy devices to remove clots from blood vessels.

    By • Jan. 15, 2026
  • A birds-eye picture of a stethoscope and piggy bank against a blue background
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Digital health funding increases in 2025, spurred by AI: report

    Startups raised $14.2 billion last year, the highest funding total since 2022. Health AI companies collected 54% of total funding, according to Rock Health.

    By Emily Olsen • Jan. 15, 2026
  • Three stacked wooden cubes on the right side of the frame read "M&A"
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Smith & Nephew to acquire Integrity Orthopaedics for up to $450M

    The company has committed the cash, half of which it is paying upfront, to buy Integrity Orthopaedics for its rotator cuff repair system.

    By • Jan. 14, 2026
  • Boston Scientific's headquarters building is shown.
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Boston Scientific to buy incontinence device maker Valencia

    The deal would set up Boston Scientific to compete with Medtronic in the market for neuromodulation devices that work by stimulating the tibial nerve.

    By • Jan. 12, 2026
  • A corporate building for Edwards Lifesciences.
    Image attribution tooltip
    Courtesy of Edwards Lifesciences
    Image attribution tooltip

    Edwards calls off JenaValve buyout after court halts deal

    Edwards terminated the deal after the Federal Trade Commission moved to block the acquisition due to anticompetitive concerns.

    By • Jan. 12, 2026
  • An image of a medical device with a white and blue handle, a metal rod and a circular tip.
    Image attribution tooltip
    Permission granted by Haemonetics
    Image attribution tooltip

    Haemonetics to acquire Vivasure Medical

    The purchase is expected to expand Haemonetics’ impact in fast-growing markets for structural heart and endovascular procedures.

    By • Jan. 9, 2026
  • Two people view Medtronic's Hugo robotic surgery system in an operating room.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip
    Deep Dive

    4 medtech topics to watch in 2026

    From insurance coverage questions to M&A and tariffs, here are the top storylines to watch in the medical device space in 2026.

    By • Jan. 8, 2026
  • A doctor examines a patient's eyes using a light and a microscope.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    STAAR shareholders reject Alcon’s revised buyout offer

    The implantable lens maker said it would remain a stand-alone company after its shareholders turned down Alcon’s $1.6 billion offer.

    By • Jan. 6, 2026
  • An illustration of DNA against a blue abstract background
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Natera acquires Foresight Diagnostics for up to $450M

    Foresight’s technology will be integrated into Natera’s Signatera platform and is expected to be launched for clinical use in 2026.

    By • Dec. 10, 2025
  • Two business people signing a contract
    Image attribution tooltip
    simarik via Getty Images
    Image attribution tooltip

    Teleflex inks deals to sell 3 businesses for $2B

    Needham analysts said Teleflex’s inability to secure a price above the low end of their expectations could reflect “the continued poor performance of UroLift.”

    By • Dec. 10, 2025
  • A warehouse with rows of packages
    Image attribution tooltip
    Courtesy of Medline
    Image attribution tooltip

    PitchBook: AI tuck-in deals to drive M&A acceleration in 2026

    Buyers will focus on “tuck-ins that add AI or data-driven capabilities or can meaningfully improve scale against emerging competitors,” the analysts said.

    By • Dec. 3, 2025
  • A person stands in front of the screen of a machine on wheels, near a sign that says "GE HealthCare"
    Image attribution tooltip
    Stringer via Getty Images
    Image attribution tooltip

    GE HealthCare to buy Intelerad for $2.3B

    GE HealthCare forecast Intelerad’s revenue to be approximately $270 million in the first full year of ownership. The deal expands GE HealthCare’s presence in more outpatient settings.

    By • Nov. 21, 2025
  • M&A due diligence lawyers legal
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Solventum inks $725M Acera takeover

    The company has stepped up its interest in M&A since making a $4.1 billion divestiture that strengthened its balance sheet.

    By • Nov. 21, 2025
  • Senior Research Associate Tanya Quint loads one of the instruments used to run Exact Sciences' Cologuard test at the company's headquarters in Madison, Wis. (Photo: Business Wire)
    Image attribution tooltip
    Courtesy of Business Wire/Exact Sciences
    Image attribution tooltip

    Abbott’s $21B Exact Sciences buy reveals future strategy

    The proposed deal, the biggest under CEO Robert Ford’s tenure, would allow Abbott to enter a large, new market for cancer testing. 

    By • Nov. 21, 2025